Cargando…

Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 – A theoretical perspective

COVID-19 is an airway disease that has affected ~125 million people worldwide, caused by a novel coronavirus termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), spread through respiratory droplets, direct contact, and aerosol transmission. Although most patients presenting with absen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaqinuddin, Ahmed, Ambia, Ayesha Rahman, Elgazzar, Tasnim Atef, AlSaud, Maha bint Mishari, Kashir, Junaid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032597/ https://www.ncbi.nlm.nih.gov/pubmed/33878626 http://dx.doi.org/10.1016/j.mehy.2021.110592

Ejemplares similares

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
por: Kwapisz, Dorota, et al.
Publicado: (2023)

Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
por: Hooper, John A.
Publicado: (2008)

Hydroxychloroquine-Induced Myopathy Responding to Intravenous Immunoglobulin (IVIG)
por: Almoallim, Hani, et al.
Publicado: (2023)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19
por: Kashir, Junaid, et al.
Publicado: (2020)

Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents
por: Yaqinuddin, Ahmed, et al.
Publicado: (2020)

Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop
por: Yaqinuddin, Ahmed, et al.
Publicado: (2020)

Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study
por: Cai, Jiang Hui, et al.
Publicado: (2022)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
por: Gill, Parwinder K., et al.
Publicado: (2018)

COVID-19: Role of neutrophil extracellular traps in acute lung injury
por: Yaqinuddin, Ahmed, et al.
Publicado: (2020)

Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids: An Acute Presentation
por: Ambia, Ayesha R, et al.
Publicado: (2022)

Streptococcus Pneumoniae-Related Hemophagocytic Lymphohistiocytosis Treated with Intravenous Immunoglobulin (IVIG) and Steroids
por: Dumancas, Carissa Y., et al.
Publicado: (2018)

Transient lymphadenopathy during intravenous immunoglobulin (IVIg) in a patient with pemphigus vulgaris
por: Foulad, Delila Pouldar, et al.
Publicado: (2021)

COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response
por: Kashir, Junaid, et al.
Publicado: (2021)

Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia
por: Lok, Ker Zhing, et al.
Publicado: (2015)

Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
por: Yaqinuddin, Ahmed, et al.
Publicado: (2021)

Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique
por: Bekele, Bisrat, et al.
Publicado: (2023)

The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients’: a retrospective, multi-centric cohort study
por: Salehi, Mohammadreza, et al.
Publicado: (2022)

Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation
por: Käsermann, Fabian, et al.
Publicado: (2012)

Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke
por: Widiapradja, Alexander, et al.
Publicado: (2014)

Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review
por: Hsia, Cyrus C., et al.
Publicado: (2015)

Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
por: Straubel, Diana, et al.
Publicado: (2018)

Efficacy of intravenous immunoglobulins (IVIG) in COVID-19 patients: a systematic review and meta-analysis
por: Fatemi, Behzad, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
por: Rossignol, Daniel A, et al.
Publicado: (2021)

Applying integrated video assisted learning approaches for medical clerkship – potential adaptations in the post-COVID-19 era
por: Yaqinuddin, Ahmed, et al.
Publicado: (2020)

Fertilization, Oocyte Activation, Calcium Release and Epigenetic Remodelling: Lessons From Cancer Models
por: Shafqat, Areez, et al.
Publicado: (2022)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report
por: Milani, Cannon, et al.
Publicado: (2009)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Remarkable benefits of intravenous immunoglobulin (IVIG) in a patient with polymyositis-associated acute interstitial lung disease
por: Peshbahar, Soran, et al.
Publicado: (2020)

Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
por: Mohtadi, Negar, et al.
Publicado: (2020)

Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis
por: Xiang, Huai-rong, et al.
Publicado: (2021)

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
por: Vanderven, Hillary A., et al.
Publicado: (2023)

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
por: Blackhouse, Gord, et al.
Publicado: (2010)

Cardiac rhythm abnormalities during intravenous immunoglobulin G(IVIG) infusion in two newborn infants: coincidence or association?
por: Tufekci, Sinan, et al.
Publicado: (2015)

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021)

Treatment of refractory delayed onset heparin‐induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG)
por: Doucette, Kimberley, et al.
Publicado: (2017)

Effect of intravenous immunoglobulin (IVIg) on primate complement-dependent cytotoxicity of genetically engineered pig cells: relevance to clinical xenotransplantation
por: Yamamoto, Takayuki, et al.
Publicado: (2020)

Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia
por: Geriak, Matthew, et al.
Publicado: (2022)

Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children
por: Hajjari, Parisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ogt319cndedsoepcgtp0a8v82b